CEACAM5 and colitis: On the other hand, transfer of CEA-CAR Tregs ameliorated CEA-CAR Teff-transferred colitis, AOM–DSS-induced colitis and colitis-associated colorectal cancer more efficiently than that of control CAR Tregs (45).